{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:49:02Z","timestamp":1784944142013,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Phenylketonuria is an autosomal recessive disorder characterized by the deficiency of phenylalanine hydroxylase, which converts phenylalanine into tyrosine. Diagnosis and prompt initiation of appropriate treatment shortly after birth are important for achieving optimal outcomes in phenylketonuria. IDMP-PKU is an ongoing study to gain insight into the patient journey and identify the unmet needs and areas for improvement in diagnosis, treatment, and follow-up of PKU in T\u00fcrkiye.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>To present the rationale and design of the IDMP-PKU study, as well as the findings from an interim analysis, describing baseline demographic, diagnosis, family history, and genetic testing data for 1553 children enrolled in the study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>This is a multicenter, observational registry-based study, conducted in 3 tertiary pediatric metabolic clinics in T\u00fcrkiye. The study provides a descriptive analysis of baseline demographic, diagnosis, family history, and genetic testing data of study population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study included 1,553 patients (median age: 10 (IQR 5\u201318) years; 37.1% classical PKU) from 90% of the cities in T\u00fcrkiye, diagnosed between 1981 and 2022. Parental consanguinity was reported in 43.5% of families (27.1% first cousins). The most frequently detected allelic variant was c.1066-11G\u2009&gt;\u2009A (IVS-10-11G\u2009&gt;\u2009A) (22.8%). Homozygous mutations were more common in patients with parental consanguinity (76.8% vs 17.1%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The median time to diagnosis improved to 21\u00a0days after the implementation of the national newborn screening (NBS) program in December 2006 but 28.6% of patients were diagnosed after one month of age. Low level of maternal education was associated with longer time to diagnosis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Implementation of national NBS has contributed to earlier identification of patients with PKU. Increasing the number of screening laboratories and pediatric metabolic clinics will speed up the diagnostic process and help achieve the guideline-recommended time for diagnosis and initiation of treatment. In countries with high rates of consanguineous marriages, increasing public awareness of PKU and genetic counselling before marriage will be valuable in reducing the prevalence of PKU.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03702-7","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T16:13:34Z","timestamp":1754064814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A comprehensive integrated disease management program for phenylketonuria (IDMP-PKU) from T\u00fcrkiye: rationale, design and patient characteristics"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3384-8679","authenticated-orcid":false,"given":"Mehmet Cihan","family":"Balci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Kor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilmaz","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Derya","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca Burcu","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alihan","family":"Yesil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Burgac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kismet","family":"Ciki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Selamioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Koseci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halise Neslihan","family":"Mungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Sivri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulden Fatma","family":"Gokcay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Tokatli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubeccel","family":"Demirkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgay","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Ozalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"9750","key":"3702_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376(9750):1417\u201327.","journal-title":"Lancet"},{"issue":"2","key":"3702_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","volume":"107","author":"A Hillert","year":"2020","unstructured":"Hillert A, Anikster Y, Belanger-Quintana A, Burlina A, Burton BK, Carducci C, et al. The genetic landscape and epidemiology of phenylketonuria. Am J Hum Genet. 2020;107(2):234\u201350.","journal-title":"Am J Hum Genet"},{"key":"3702_CR3","unstructured":"PAHvdb: Phenylalanine Hydroxylase Gene Locus-Specific Database [Available from: http:\/\/www.biopku.org\/home\/pah.asp."},{"key":"3702_CR4","unstructured":"Stone WL BH, Los E. Phenylketonuria: Treasure Island (FL): StatPearls Publishing; 2024 [StatPearls]. Available from: www.ncbi.nlm.nih.gov\/books\/NBK535378\/."},{"issue":"1","key":"3702_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40246-022-00398-9","volume":"16","author":"NA Elhawary","year":"2022","unstructured":"Elhawary NA, AlJahdali IA, Abumansour IS, Elhawary EN, Gaboon N, Dandini M, et al. Genetic etiology and clinical challenges of phenylketonuria. Hum Genomics. 2022;16(1):22.","journal-title":"Hum Genomics"},{"issue":"2","key":"3702_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188\u2013200.","journal-title":"Genet Med"},{"issue":"1","key":"3702_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3702_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.24953\/turkjped.2021.4098","volume":"64","author":"T Co\u015fkun","year":"2022","unstructured":"Co\u015fkun T, \u00c7oker M, Mungan N, \u00d6zel HG, Sivri HS. Recommendations on phenylketonuria in Turkey. Turk J Pediatr. 2022;64(3):413\u201334.","journal-title":"Turk J Pediatr"},{"key":"3702_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338\u201343.","journal-title":"Pediatrics"},{"issue":"2","key":"3702_CR10","first-page":"123","volume":"21","author":"JT Wu","year":"1991","unstructured":"Wu JT. Screening for inborn errors of amino acid metabolism. Ann Clin Lab Sci. 1991;21(2):123\u201342.","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"3702_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/clinchem\/39.1.66","volume":"39","author":"DH Chace","year":"1993","unstructured":"Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem. 1993;39(1):66\u201371.","journal-title":"Clin Chem"},{"key":"3702_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmsacl.2024.01.006","volume":"32","author":"DS Millington","year":"2024","unstructured":"Millington DS. How mass spectrometry revolutionized newborn screening. J Mass Spectrom Adv Clin Lab. 2024;32:1\u201310.","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"1","key":"3702_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10545-008-0952-4","volume":"32","author":"DM Ney","year":"2009","unstructured":"Ney DM, Gleason ST, van Calcar SC, MacLeod EL, Nelson KL, Etzel MR, et al. Nutritional management of PKU with glycomacropeptide from cheese whey. J Inherit Metab Dis. 2009;32(1):32\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"3702_CR14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s10545-006-0395-8","volume":"29","author":"R Matalon","year":"2006","unstructured":"Matalon R, Michals-Matalon K, Bhatia G, Grechanina E, Novikov P, McDonald JD, et al. Large neutral amino acids in the treatment of phenylketonuria (PKU). J Inherit Metab Dis. 2006;29(6):732\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"9586","key":"3702_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","volume":"370","author":"HL Levy","year":"2007","unstructured":"Levy HL, Milanowski A, Chakrapani A, Cleary M, Lee P, Trefz FK, et al. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet. 2007;370(9586):504\u201310.","journal-title":"Lancet"},{"issue":"1","key":"3702_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymgme.2018.03.003","volume":"124","author":"CO Harding","year":"2018","unstructured":"Harding CO, Amato RS, Stuy M, Longo N, Burton BK, Posner J, et al. Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial. Mol Genet Metab. 2018;124(1):20\u20136.","journal-title":"Mol Genet Metab"},{"key":"3702_CR17","unstructured":"Do\u011fum \u0130statistikleri, 2021 (In Turkish; Birth statistics,2021) [Available from: https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Dogum-Istatistikleri-2021-45547."},{"key":"3702_CR18","unstructured":"Program \u0130statistikleri - Yenido\u011fan Metabolik ve Endokrin Hastal\u0131k Taramas\u0131 (In Turkish; Program Statistics - Newborn Screening for Metabolic and Endocrine Disease) [Available from: https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/cocuk-ergen-sagligi-db\/Dokumanlar\/Istatistikler\/NTP.pdf."},{"key":"3702_CR19","unstructured":"Yenido\u011fan Metabolik ve Endokrin Hastal\u0131k Tarama Program\u0131 (In Turkish; Newborn Screening for Metabolic and Endocrine Disease Program) [Available from: https:\/\/hsgm.saglik.gov.tr\/tr\/tarama-programlari\/ntp.html."},{"key":"3702_CR20","unstructured":"Pediatrik beslenme ve metabolizma klinikleri (In Turkish; Pediatric nutrition and metabolic clinics) [Available from: https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/cocuk-ergen-sagligi-db\/Programlar\/Pediatrik_Metabolizma_Klinikleri_Listesi.pdf."},{"key":"3702_CR21","unstructured":"T\u00fcrkiye\u2019de illere g\u00f6re n\u00fcfus (In Turkish; Population of cities in Turkey) [Available from: https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Adrese-Dayali-Nufus-Kayit-Sistemi-Sonuclari-2023-49684."},{"issue":"5","key":"3702_CR22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/adc.65.5.472","volume":"65","author":"I Smith","year":"1990","unstructured":"Smith I, Beasley MG, Ades AE. Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child. 1990;65(5):472\u20138.","journal-title":"Arch Dis Child"},{"issue":"2","key":"3702_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00431-015-2622-5","volume":"175","author":"M Gi\u017cewska","year":"2016","unstructured":"Gi\u017cewska M, MacDonald A, B\u00e9langer-Quintana A, Burlina A, Cleary M, Co\u015fkun T, et al. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results. Eur J Pediatr. 2016;175(2):261\u201372.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"3702_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2021.10.001","volume":"134","author":"A Kenneson","year":"2021","unstructured":"Kenneson A, Singh RH. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry. Mol Genet Metab. 2021;134(3):243\u20139.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"3702_CR25","volume":"11","author":"EMTF Rezabeigi Davarani","year":"2022","unstructured":"Rezabeigi Davarani EMTF, Daneshi S, Sanjari P, Khanjani N, Hushmandi K, Raei M. Assessing the phenylketonuria (PKU) neonatal screening program and the incidence rates of PKU in Kerman County, Iran: health system research. J Pediatr Neonat Individual Med. 2022;11(2): e110217.","journal-title":"J Pediatr Neonat Individual Med"},{"issue":"3","key":"3702_CR26","first-page":"402","volume":"9","author":"S Dababneh","year":"2022","unstructured":"Dababneh S, Alsbou M, Taani N, Sharkas G, Ismael R, Maraqa L, et al. Epidemiology of phenylketonuria disease in Jordan: medical and nutritional challenges. Children (Basel). 2022;9(3):402.","journal-title":"Children (Basel)."},{"key":"3702_CR27","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2024\/42\/2022161","volume":"42","author":"RD Costa","year":"2023","unstructured":"Costa RD, Ferreira MFC, Rocha TA, Galera MF. Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019. Rev Paul Pediatr. 2023;42: e2022161.","journal-title":"Rev Paul Pediatr"},{"issue":"1","key":"3702_CR28","first-page":"49","volume":"5","author":"PEM Savli","year":"2022","unstructured":"Savli PEM, Guner AE, Tas I. Evaluation of babies with hyperphenylalaninemia diagnosed in the National Newborn Screening Program in Istanbul in 2019. Int J Med Biochem. 2022;5(1):49\u201353.","journal-title":"Int J Med Biochem"},{"issue":"5","key":"3702_CR29","first-page":"571","volume":"11","author":"B Kad\u0131o\u011flu Y\u0131lmaz","year":"2024","unstructured":"Kad\u0131o\u011flu Y\u0131lmaz B, Ba\u011fc\u0131 Z. Delays in Newborn screening for phenylketonuria from birth to diagnosis and factors affecting this. Children (Basel). 2024;11(5):571.","journal-title":"Children (Basel)."},{"key":"3702_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/718674","volume":"2015","author":"A Al-Sulaiman","year":"2015","unstructured":"Al-Sulaiman A, Kondkar AA, Saeedi MY, Saadallah A, Al-Odaib A, Abu-Amero KK. Assessment of the knowledge and attitudes of saudi mothers towards newborn screening. Biomed Res Int. 2015;2015: 718674.","journal-title":"Biomed Res Int"},{"issue":"3","key":"3702_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ijns5030035","volume":"5","author":"V Frankov\u00e1","year":"2019","unstructured":"Frankov\u00e1 V, Dohnalov\u00e1 A, Pe\u0161kov\u00e1 K, Herm\u00e1nkov\u00e1 R, O\u2019Driscoll R, Je\u0161ina P, et al. Factors influencing parental awareness about newborn screening. Int J Neonatal Screen. 2019;5(3):35.","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"3702_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12687-021-00572-x","volume":"13","author":"A Kasem","year":"2022","unstructured":"Kasem A, Razeq NMA, Abuhammad S, Alkhazali H. Mothers\u2019 knowledge and attitudes about newborn screening in Jordan. J Community Genet. 2022;13(2):215\u201325.","journal-title":"J Community Genet"},{"issue":"6","key":"3702_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12687-023-00659-7","volume":"14","author":"T Kadiro\u011flu","year":"2023","unstructured":"Kadiro\u011flu T, Altay G, Akay G, Can B\u00c7. Identification of maternal attitudes and knowledge about newborn screenings: a Turkey sample. J Commun Genet. 2023;14(6):555\u201364.","journal-title":"J Commun Genet"},{"issue":"3","key":"3702_CR34","doi-asserted-by":"publisher","first-page":"e007780","DOI":"10.1136\/bmjgh-2021-007780","volume":"7","author":"V Koracin","year":"2022","unstructured":"Koracin V, Loeber JG, Mlinaric M, Battelino T, Bonham JR, Groselj U. Global impact of COVID-19 on newborn screening programmes. BMJ Glob Health. 2022;7(3):e007780.","journal-title":"BMJ Glob Health"},{"key":"3702_CR35","doi-asserted-by":"crossref","unstructured":"Cakmak S YY, Kanburo\u011flu MK. COVID-19 Pandemisinin Yenido\u011fan Tarama Program\u0131 Hizmetleri \u00dczerine Etkileri. (Article in Turkish; The Effects of the COVID-19 Pandemic on Newborn Screening Program Services) SABD. 2022;12(2):224\u20139.","DOI":"10.33631\/sabd.1112649"},{"key":"3702_CR36","doi-asserted-by":"crossref","unstructured":"Esmeray 0 \u00d6C, \u00c7etin H, \u015eim\u015fek EE. Bir e\u011fitim aile sa\u011fl\u0131\u011f\u0131 merkezinin COVID-19 pandemi deneyiminin incelenmesi. (Article in Turkish; Evaluation of the COVID-19 pandemia experience of a family health center) Acta Med Nicomedia. Haziran 2021;4(2):56\u201363.","DOI":"10.53446\/actamednicomedia.884834"},{"key":"3702_CR37","unstructured":"Selamio\u011flu A KM, Balc\u0131 MC, Burmac\u0131 Can N, G\u00f6k\u00e7ay, GF. Covid- 19 Pandemisinin Fenilketon\u00fcri Yenido\u011fan Tarama Program\u0131 \u00dczerine Etkileri Presented at 2nd International Congress of Pediatrics and Gynecology; 21 -24October 2021 Antalya, T\u00fcrkiye."},{"key":"3702_CR38","unstructured":"2018 N\u00fcfus ve Sa\u011fl\u0131k Ara\u015ft\u0131rmas\u0131 (in Turkish: The 2018 Turkey Demographic and Health Survey Hacettepe University Institute of Population Studies): Hacettepe \u00dcniversitesi N\u00fcfus Et\u00fctleri Enstit\u00fcs\u00fc, T.C. Cumhurba\u015fkanl\u0131\u011f\u0131 Strateji ve B\u00fct\u00e7e Ba\u015fkanl\u0131\u011f\u0131 ve T\u00fcbitak; [Available from: http:\/\/www.sck.gov.tr\/wp-content\/uploads\/2020\/08\/TNSA2018_ana_Rapor.pdf."},{"key":"3702_CR39","unstructured":"\u0130statistiklerle Aile, 2023 (in Turkish; Family Statistics, 2023) [Available from: https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Istatistiklerle-Aile-2023-53784."},{"key":"3702_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s44162-022-00004-5","author":"GNN Temaj","year":"2022","unstructured":"Temaj GNN, Sayer JA. The impact of consanguinity on human health and disease with an emphasis on rare diseases. J Rare Dis. 2022. https:\/\/doi.org\/10.1007\/s44162-022-00004-5.","journal-title":"J Rare Dis"},{"issue":"6","key":"3702_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.24953\/turkjped.2022.467","volume":"64","author":"\u0130 Tokta\u015f","year":"2022","unstructured":"Tokta\u015f \u0130, Sar\u0131ba\u015f S, Canpolat S, Erdem \u00d6, \u00d6zbek MN. Evaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective study. Turk J Pediatr. 2022;64(6):985\u201392.","journal-title":"Turk J Pediatr"},{"key":"3702_CR42","unstructured":"Oz S. \u00c7ukurova \u00dcniversitesi Pediatrik Metabolizma ve Beslenme Bilim Dal\u0131\u2019nda izlenen hiperfenilalaninemili hastalar\u0131n demografik, klinik ve genetik \u00f6zellikleri (Dissertation in Turkish; Demographic, clinical and genetic characteristics of patients with hyperphenylalaninemia followed-up in \u00c7ukurova University Department of Pediatric Metabolism and Nutrition) Adana Turkey; Cukurova University, 2018."},{"issue":"6","key":"3702_CR43","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10545-018-0228-6","volume":"41","author":"T Shirzadeh","year":"2018","unstructured":"Shirzadeh T, Saeidian AH, Bagherian H, Salehpour S, Setoodeh A, Alaei MR, et al. Molecular genetics of a cohort of 635 cases of phenylketonuria in a consanguineous population. J Inherit Metab Dis. 2018;41(6):1159\u201367.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3702_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/jmg.30.2.129","volume":"30","author":"M Ozg\u00fc\u00e7","year":"1993","unstructured":"Ozg\u00fc\u00e7 M, Ozalp I, Co\u015fkun T, Yilmaz E, Erdem H, Ayter S. Mutation analysis in Turkish phenylketonuria patients. J Med Genet. 1993;30(2):129\u201330.","journal-title":"J Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03702-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03702-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03702-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:24:21Z","timestamp":1757330661000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03702-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3702"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03702-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Cukurova University, Faculty of Medicine, Clinical Research Ethics Committee approved the study (trial code: MON562.328.2) and related documents (19.11.2020\u2013137\/8). The protocol amendment for inclusion of SCL-90 and KBIT-2 tests as additional neurocognitive assessments, was also approved by the Ethics Committee (12.05.2022 -168\/11).BU SONU\u00c7LARA YER VER\u0130LMED\u0130 AMA ANA \u00c7ALI\u015eMA \u0130LE \u0130L\u0130GL\u0130 OLDU\u011eUNDNA KALMALI D\u0130YE D\u00dc\u015e\u00dcN\u00dcYORUM, The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice Guidelines. Written informed consent was obtained from all volunteers or their legal guardians after the study procedures were explained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors confirm that they do not have any potential conflict of interest. The authors confirm independence from the sponsors; the content of the article has not been influenced by the sponsors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}